Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded
- Contract number
- SPE2DR26FK178
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,253
Award facts
- Contract value 100% obligated
- $19,252.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19,252.90 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Wegovy 2.4 mg/0.75 mL pen injectors. The contract, which is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 29, 2025. As a non-set-aside, competitively awarded contract, this delivery order reflects the Defense Logistics Agency's sourcing of pharmaceutical products through AmerisourceBergen's comprehensive global pharmaceutical support vehicle, which supplies a wide range of brand-name and generic medications to military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor that serves as a critical federal medical procurement vendor, particularly for Defense Health Agency and military healthcare systems. The company's extensive federal contract portfolio demonstrates its capacity to fulfill diverse medical supply requirements through competitive procurement, ranging from small-value transactions to substantial orders exceeding $45,000. This specific delivery order for Wegovy, a GLP-1 receptor agonist medication, aligns with the contractor's established track record of supplying specialized pharmaceuticals across multiple therapeutic domains to support military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FK178?
SPE2DR26FK178 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DR26FK178 worth?
The government has obligated $19,253 on SPE2DR26FK178.
Is contract SPE2DR26FK178 an order under another contract?
Yes. SPE2DR26FK178 is a delivery order under SPE2DR25D1104, an indefinite delivery contract.
Was contract SPE2DR26FK178 competed?
The extent of competition for SPE2DR26FK178 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award